NovaBay Pharmaceuticals has announced a strategic pivot, rebranding as Stablecoin Development Corporation and transitioning to an on-chain treasury model. The company will begin trading under the ticker SDEV on the NYSE American from April 3. This move marks a significant shift from its pharmaceutical roots to a crypto-focused business model, emphasizing staking and on-chain activities. The company disclosed holdings of approximately 2.06 billion SKY tokens as of March 16, engaging in staking to generate yield. This strategy aligns with decentralized finance (DeFi) principles, focusing on active participation in network operations rather than passive crypto holding. NovaBay's approach contrasts with traditional corporate Bitcoin strategies, emphasizing yield generation through blockchain network activities. This transformation reflects a broader trend of corporate crypto adoption, with firms integrating crypto into their core operations. By rebranding and focusing on stablecoin and DeFi infrastructure, NovaBay signals a deeper commitment to evolving financial models, highlighting the intersection of traditional corporate structures with decentralized systems.